CClinicalTrials.gg
CompletedNCT02727010MMOMAUpdated May 29, 2018

Motherhood With MOtor Impairment Due to MAlady (Rare Disease)

An observational study in Disability Evaluation and Child of Impaired Parents, sponsored by Assistance Publique - Hôpitaux de Paris. Completed at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-05-29.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
29
Ages
18 Years and older
Sex
Female
01

Study summary

Background Women with rare diseases resulting in motor disabilities wishing to become mother face a major challenge. The investigators hypothesize that provided with adequate support, they are able to achieve a successful pregnancy and to offer their child a safe family environment.

Methods To test this hypothesis, the investigators shall conduct a prospective observational prospective survey of a consecutive series of volunteer pregnant women or mothers of children less than 14 months, with motor impairment, participating in a program of parenting support developed in our institution.

Primary outcome: social environment, child development, mother-infant attachment, mother- infant interactions Secondary outcome: social and demographic characteristics, severity of motor impairment, associated impairment, perinatal morbidity for the mother and the infant (composite indicator), emotional status, and the needs expressed by women regarding the level of medical or social care.

Analysis The investigators shall describe the distribution of the primary outcome measurements in the subgroup of women with motor impairment related to a rare disease. The investigators shall compare this distribution to the expected distribution in the general population, and to that observed in women with motor impairment unrelated to a rare disease. The investigators shall also study primary outcome measurements as a function of the severity of maternal disability, of the mother's social characteristics and emotional status.

The investigators shall also describe the distribution the distribution of perinatal morbidity globally, and as a function of the potential explanatory variables mentioned above.

The investigators shall also report on the opinion of women regarding the support they were offered so far, and the support they declare they should benefit from.

Read the detailed description

Background Women with motor disabilities have the same well-founded desire to become a mother as other women. Despite dedicated aids and adapted supportive measures, they face social blame from persons who believe they are not apt to provide adequate care to their children. When a rare disease caused the disability, planning to become a mother is even more critical, since most perinatal care providers are unfamiliar with the condition, and specialists of the disease are unfamiliar with pregnancy. Unsurprisingly, data on motherhood in women with rare diseases resulting in motor impairment are scarce.

The institutions of the investigators run a joint care program dedicated to future parents and parents with disabilities, namely:

  • Hôpital Universitaire Pitié Salpêtrière- Charles Foix (assistance Publique Hôpitaux de Paris and Université Paris 6), providing a gynecological and perinatal unit with care programs adapted to women with disabilities, plus a number of reference centers for rare neurologic and muscular diseases including research and clinical care.
  • Service d'Aide à la Parentalité des Personnes en Situation de Handicap (SAPPH, Fondation Hospitalière Sainte Marie) providing training and support to parenthood to persons with motor or sensory disabilities. This training program aims at recognizing parental capacities, and if necessary enhancing them by information, training, adapting the environment, or seeking extra human help.

The investigators felt the need to evaluate the outcome of our program, in terms of quality of infant environment, development, attachment, and interactions with their disabled mother. The investigators focused on parenthood in women with a rare disease resulting in motor impairment, a research field remaining largely unexplored so far.

Hypothesis Our hypothesis is that when provided with a specific care program, mothers with motor impairment due to a rare disease and their partners have the capacity to offer their children appropriate social environment and care, resulting in child development, mother-infant attachment, and mother- infant interactions being similar to what one would expect in women without motor impairment.

Objective Primary objective To describe social environment, child development, mother-infant attachment, mother- infant interactions, when the mother has motor impairment due du a rare disease.

Secondary objective

  1. To describe maternal and perinatal outcome when the mother has motor impairment due du a rare disease
  2. To explore a potential relation between the outcome criteria of the primary goal with

    • The severity of motor impairment
    • The causal disease
    • The personal history of the mother including her access to adapted care prior to pregnancy during pregnancy and post-partum
    • The social status of the family
    • The emotional status of the mother
  3. To compare the distribution of primary goal outcome criteria in our study population to what is expected in the general population, when appropriate
  4. To compare the distribution of primary goal outcome criteria in our study population to what we observed in women with motor impairment that does not result from a rare disease
  5. To describe the needs expressed by women regarding medical care, psychological, social, and environmental support

Eligibility criteria Please see specific box

Outcome measurements (assessed at least once before the age of 14 months, see specific box) Primary outcome Child development /Infant attachment /Social environment /Mother infant interaction/ Child protection legal decisions if applicable Secondary outcome Demographic and social characteristics Disease or event causing impairment Obstetrical history Somatic and psychic events before, during pregnancy, and post-partum History of access to care Severity of impairment and handicap Maternal emotional status Needs expressed by women regarding medical care, psychological, social, and environmental support

Study design Pre inclusion: written and verbal information on the study to all women with motor impairment seeking care either at the Pitié Salpétrière Maternity unit or at the Service d'Aide à la Parentalité pour les Personnes en Situation de Handicap (SAPPH) Inclusion visit: During a planned training session, either pre natal or post natal Follow up visit: once of twice before the child is 14 months. A specific consent of both parents will be required for all outcome criteria concerning the infant.

Research visits will take place during usual visits of our parenthood support and training program.

Analysis The investigators shall describe the distribution of the primary outcome measurements in the subgroup of women with motor impairment related to a rare disease. The investigators shall compare this distribution to the expected distribution in the general population, and to that observed in women with motor impairment unrelated to a rare disease. The investigators shall also study primary outcome measurements as a function of the severity of maternal disability, of the mother's social characteristics and emotional status.

The investigators shall also describe the distribution the distribution of perinatal morbidity globally, and as a function of the potential explanatory variables mentioned above.

the investigators shall also report on the opinion of women regarding the support they were offered so far, and the support they declare they should benefit from.

02

Conditions studied

  • Disability Evaluation
  • Child of Impaired Parents

Browse trials for

Keywords

  • Motor disability
  • Motor impairment
  • Pregnancy
  • Parenthood
  • Child psychology
03

In context

Rare Diseases

203 studies on the registry are indexed under Rare Diseases; 112 are open to participants now.

This study's enrollment of 29 is below the median of 200 across 125 observational studies indexed under Rare Diseases.

Browse Rare Diseases studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pregnant women or mothers to children \< 14 months, with motor impairment, visiting the inclusion center and willing to participate in the study. Any motor impairment available, regardless of its cause.

Inclusion criteria

  • Women aged 18 or older
  • Either pregnant > 14 weeks, or mother of a child \< 1 year
  • With disability resulting from motor impairment
  • Giving informed consent
  • With social insurance

Exclusion criteria

Exclusion Criteria:

  • Know mental retardation
  • Known psychiatric disorder
  • Not fluent in French
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
29 participants (actual)
Patient registry
No

Groups and cohorts

  • mothers with motor impairment due to a rare disease

    20 Women with motor impairment due to a rare disease

  • mothers with motor impairment not related to a rare disease

    controls, 20 women with motor impairment not related to a rare disease

06

What researchers measure

Primary outcomes

  1. Child development Mother infant attachment - Coding Interactive Behavior - Pirgas scale - Child protection legal decisions if applicable

    Child development assessed by Brunet Lézine score: based on standardized examination of the infant by a trained child psychologist

    Time frame: At least once before the age of 14 months. May be repeated twice.

  2. Infant attachment

    Infant attachment assessed by Guedenet and Fermanian ADBB scale: scale assessed by investigator

    Time frame: At least once before the age of 14 months. May be repeated twice.

  3. Social environment

    Social environment assessed by Cutrona scale: self-administered questionnaire

    Time frame: At least once before the age of 14 months. May be repeated twice.

  4. Mother infant interaction

    assessed by: * Coding Interactive Behavior: mother infant interaction filmed in a standardized fashion, and analyzed by trained psychologists blinded to the dyad's history. * Pirgas scale: clinical diagnosis regarding mother to infant interactions Child protection legal decisions : type of decision if applicable.

    Time frame: At least once before the age of 14 months. May be repeated twice.

Secondary outcomes

  1. Demographic and social characteristics

    Demographic and social characteristics, qualitative variables (Questionnaire administered by investigator)

    Time frame: At lest once before the age of 14 months. May be repeated twice.

  2. Epices score of social deprivation

    Epices score of social deprivation (Self-administered questionnaire)

    Time frame: At lest once before the age of 14 months. May be repeated twice.

  3. Disease or event causing impairment

    Disease or event causing impairment: preset qualitative variables (Questionnaire administered by investigator)

    Time frame: At lest once before the age of 14 months. May be repeated twice.

  4. Obstetrical history

    Obstetrical history: preset qualitative variables (Questionnaire administered by investigator)

    Time frame: At lest once before the age of 14 months. May be repeated twice.

  5. Somatic and psychic events before, during pregnancy, and post-partum (composite scores)

    Time frame: At lest once before the age of 14 months. May be repeated twice.

  6. History of access to care

    History of access to care: standardized interview (Questionnaire administered by investigator)

    Time frame: At lest once before the age of 14 months. May be repeated twice.

  7. Barthel score of capacity in everyday life

    Barthel score of capacity in everyday life (Self-administered questionnaire)

    Time frame: At lest once before the age of 14 months. May be repeated twice.

  8. Ad hoc ordinal score based on the number of body parts with motor impairment and additional non-motor impairment

    Time frame: At lest once before the age of 14 months. May be repeated twice.

  9. Maternal emotional status

    Assessed by STAI / EPDS scales (Self-administered questionnaire)

    Time frame: At lest once before the age of 14 months. May be repeated twice.

  10. List of the needs expressed by women regarding medical care, psychological, social, and environmental support

    Assessed self-administered questionnaire

    Time frame: At lest once before the age of 14 months. May be repeated twice.

07

Study locations

1 site
  • SAPPH
    Paris, 75014, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 29, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02727010
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
Service d'Aide à la Parentalité des Personnes en Situation de Handicap (SAPPH)
Responsible party
Sponsor
First posted
Apr 4, 2016
Start date
Mar 2, 2016
Primary completion
Aug 28, 2017
Completion
Nov 28, 2017
Last update
May 29, 2018

Study contacts

Drina Candilis, PhD
principal investigator · SAPPH

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion